Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Share transactions in Remote Monitored Systems plc

9 Nov 2020 07:00

RNS Number : 5885E
Braveheart Investment Group plc
09 November 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

9 November 2020

Braveheart Investment Group plc

("Braveheart" or the "Group")

Share transactions in Remote Monitored Systems plc

 

Braveheart announces that on 6 November 2020 it exercised a total of 10 million options over ordinary shares in Remote Monitored Systems plc ("RMS") at an exercise price of 0.5p per share ("the RMS Option Shares") and an aggregate cost of £50,000. Braveheart has been advised that application will be made by the directors of RMS for the RMS Option Shares to be admitted to trading on the AIM market and that dealings are expected to commence on or about 13 November 2020.

Braveheart also announces that on 5 and 6 November 2020, it sold a total of 120 million ordinary shares in RMS at a weighted average price of 2.6265p per share, realising gross proceeds of approximately £3.15 million. The net funds receivable by Braveheart are primarily intended to fund the COVID-19 test project, as required and assuming it continues to deliver the results necessary to justify continuing the project, being conducted by Paraytec Limited through to a point where it is ready for commercial launch. Following these sales, Braveheart holds 389,992,405 RMS shares, representing 25.45 per cent. of the voting rights of RMS and following the admission to AIM of the RMS Option Shares will hold 399,992,405 RMS shares, representing 25.94 per cent. of the then enlarged voting rights of RMS.

About RMS

RMS is an operating company whose ordinary shares are admitted to trading on AIM. In the year ended 31 December 2019, RMS incurred a loss before taxation of £711,942 and as at that date had net liabilities of £19,250. As at 30 June 2020 had unaudited net assets of £674,135.

 

For further information: 

 

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, CEO

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Hornigold

 

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBPBRTMTTMBBM
Date   Source Headline
28th Oct 20107:00 amRNSFurther Investment in Biopta Ltd
6th Oct 20107:00 amRNSCompletion of Acquisition
16th Sep 20102:43 pmRNSResult of AGM
6th Sep 20107:00 amRNSFurther Investment in Elonics Ltd
1st Sep 20107:00 amRNSFurther Investment in Traak Systems Ltd
18th Aug 201010:00 amRNSAcquisition
12th Aug 20107:00 amRNSNotice of AGM
26th Jul 20107:00 amRNSFollow-on investment in AppShare
20th Jul 201010:08 amRNSAward of Options
16th Jul 20107:00 amRNSRealisation of Investment
5th Jul 201012:32 pmRNSIssue of Equity
5th Jul 20107:00 amRNSFinal Results
2nd Jul 20107:00 amRNSInvestment in mLED Limited
1st Jul 20107:00 amRNSNotice of Results
19th May 20107:00 amRNSFollow on investment in Conjunct Limited
3rd Mar 20107:00 amRNSInvestment in Tayside Flow Technologies
18th Jan 20107:00 amRNSLaunch of Beta EIS Fund
7th Dec 20097:00 amRNSInterim Results
2nd Dec 20098:54 amRNSSubsidiary Reorganisation
27th Nov 20097:00 amRNSInvesting Policy
28th Sep 20097:00 amRNSEnterprise Finance Guarantee Scheme
25th Sep 20097:00 amRNSFollow on Investment in Appshare
9th Sep 20092:28 pmRNSResult of AGM
10th Aug 20099:14 amRNSNotice of AGM and posting of Annual Report
3rd Jul 20097:00 amRNSAward of Options
1st Jul 20097:00 amRNSFollow-on Investment in NXVision
29th Jun 20097:00 amRNSFollow-on investment in Pyreos
24th Jun 20097:00 amRNSFirst investment for Strathclyde Innovation Fund
18th Jun 20097:00 amRNSFinal Results
16th Jun 20097:00 amRNSNotice of Results
8th Jun 20097:06 amRNSAcquisition
12th May 20097:00 amRNSFollow-on Investment
19th Mar 20097:00 amRNSFollow on Investment in Traak Systems
23rd Feb 20097:00 amRNSInvestment in Pufferfish
20th Jan 20094:39 pmRNSHolding(s) in Company
6th Jan 200910:18 amRNSFollow on Investment
22nd Dec 20087:00 amRNSAward of Options
8th Dec 20087:00 amRNSHalf Yearly Report
4th Dec 20083:39 pmRNSFollow-on Investment
27th Nov 20087:00 amRNSOpening of London Office
12th Nov 20087:00 amRNSSenior Management Change
16th Oct 20087:00 amRNSDirectorate Change
1st Oct 20087:00 amRNSTrading Statement
12th Sep 20084:43 pmRNSOffer Update
10th Sep 20082:27 pmRNSResult of AGM
4th Sep 200811:30 amRNSRule 8.3- Braveheart Inv. Grp
4th Sep 200811:22 amRNSRule 8.3- Braveheart Inv. Grp
26th Aug 200810:07 amRNSEPT Disclosure
21st Aug 20089:26 amRNSEPT Disclosure
18th Aug 20087:00 amRNSNotice of AGM & Directorate C

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.